INVO Bioscience (INVO) Short Interest Ratio & Short Volume $0.75 -0.01 (-1.32%) (As of 12/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends INVO Bioscience Short Interest DataINVO Bioscience (INVO) has a short interest of 2,000 shares, representing 0.05% of the float (the number of shares available for trading by the public). This marks a -96.60% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1.59 million shares to cover all short positions.Current Short Interest2,000 sharesPrevious Short Interest58,900 sharesChange Vs. Previous Month-96.60%Dollar Volume Sold Short$1,420.00Short Interest Ratio0.0 Days to CoverLast Record DateSeptember 30, 2024Outstanding Shares3,809,000 sharesFloat Size3,880,000 sharesShort Percent of Float0.05%Today's Trading Volume39,601 sharesAverage Trading Volume1,587,563 sharesToday's Volume Vs. Average2% Short Selling INVO Bioscience? Sign up to receive the latest short interest report for INVO Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINVO Short Interest Over TimeINVO Days to Cover Over TimeINVO Percentage of Float Shorted Over Time Ad Porter & CompanyVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. INVO Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/30/20242,000 shares $1,420.00 -96.6%0.1%0 $0.71 9/15/202458,900 shares $41,989.81 -51.4%1.5%0.3 $0.71 8/31/2024121,300 shares $97,185.56 -20.0%3.1%0.6 $0.80 8/15/2024151,700 shares $128,945.00 -69.5%3.9%0.8 $0.85 7/31/2024496,600 shares $446,940.00 +2,541.5%13.1%2.5 $0.90 7/15/202418,800 shares $15,754.40 -9.2%0.5%0.1 $0.84 Get the Latest News and Ratings for INVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for INVO Bioscience and its competitors with MarketBeat's FREE daily newsletter. 6/30/202420,700 shares $17,390.09 -72.6%0.6%0 $0.84 6/15/202475,600 shares $77,868.00 +144.7%2.0%0 $1.03 5/31/202430,900 shares $26,574.00 -62.0%0.8%0 $0.86 5/15/202481,300 shares $86,991.00 +146.4%2.2%0 $1.07 4/30/202433,000 shares $33,000.00 +87.5%1.2%0 $1.00 4/15/202417,600 shares $13,499.20 +45.5%0.7%0 $0.77 3/31/202412,100 shares $13,673.00 +10.0%0.5%0.4 $1.13 3/15/202411,000 shares $11,330.00 -1.8%0.5%0.4 $1.03 2/29/202411,200 shares $12,880.00 -24.3%0.5%0.2 $1.15 2/15/202414,800 shares $12,551.88 -32.4%0.6%0.1 $0.85 1/31/202421,900 shares $21,900.00 +2.3%0.9%0 $1.00 1/15/202421,400 shares $22,470.00 -51.0%0.9%0 $1.05 12/31/202343,700 shares $58,995.00 -24.4%1.8%0 $1.35 12/15/202357,800 shares $71,094.00 -70.6%N/A0 $1.23 11/30/2023196,700 shares $367,829.00 -80.3%N/A0.1 $1.87 11/15/2023997,200 shares $1.84 million +245.1%N/A0.3 $1.85 10/31/2023289,000 shares $375,700.00 +397.4%N/A0.2 $1.30 10/15/202358,100 shares $39,827.55 -52.7%N/A0 $0.69 9/30/2023122,700 shares $96,957.54 +740.4%N/A0.6 $0.79 9/15/202314,600 shares $15,184.00 -13.6%N/A0.1 $1.04 8/31/202316,900 shares $25,519.00 -86.7%N/A0.1 $1.51 8/15/2023127,400 shares $181,545.00 +182.5%N/A0.5 $1.43 7/31/202345,100 shares $223,696.00 -84.5%N/A0.2 $4.96 7/15/2023290,600 shares $51,145.60 -38.8%N/A0.2 $0.18 6/30/2023474,800 shares $95,054.96 +363.2%3.2%0.4 $0.20 6/15/2023102,500 shares $17,404.50 +94.5%0.8%0.1 $0.17 5/31/202352,700 shares $13,417.42 -28.6%0.4%0.1 $0.25 5/15/202373,800 shares $26,095.68 No Change0.6%0.4 $0.35 10/31/202259,200 shares $68,080.00 -17.2%N/A2.4 $1.15 10/15/202271,500 shares $88,660.00 +3.6%N/A2.8 $1.24 9/30/202269,000 shares $73,140.00 +102.9%N/A2.6 $1.06 9/15/202234,000 shares $49,640.00 +38.8%N/A1 $1.46 8/31/202224,500 shares $23,716.00 -63.6%N/A0.8 $0.97 8/15/202267,300 shares $76,049.00 +3.9%N/A1.5 $1.13The #1 Coin for November 2024 (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… 7/31/202264,800 shares $64,152.00 +19.8%N/A1.4 $0.99 7/15/202254,100 shares $51,936.00 -30.7%N/A1.1 $0.96 6/30/202278,100 shares $49,976.19 +65.5%N/A1.5 $0.64 6/15/202247,200 shares $41,819.20 -42.1%N/A0.9 $0.89 5/31/202281,500 shares $79,829.25 +13.5%N/A1.5 $0.98 5/15/202271,800 shares $101,956.00 +22.5%N/A1.9 $1.42 4/30/202258,600 shares $88,486.00 -34.0%N/A1.7 $1.51 4/15/202288,800 shares $166,944.00 -1.0%N/A2.1 $1.88 3/31/202289,700 shares $236,808.00 +27.1%N/A2.2 $2.64 3/15/202270,600 shares $154,614.00 +2.3%N/A1.6 $2.19 2/28/202269,000 shares $207,690.00 +63.5%N/A1.5 $3.01 2/15/202242,200 shares $127,022.00 -44.2%N/A1 $3.01 1/31/202275,600 shares $240,408.00 -12.7%N/A1.5 $3.18 1/15/202286,600 shares $312,626.00 -1.5%N/A0 $3.61 12/31/202187,900 shares $292,707.00 -26.1%N/A1.8 $3.33 12/15/2021119,000 shares $445,060.00 +104.1%N/A2.3 $3.74 11/30/202158,300 shares $179,564.00 -55.0%N/A1.1 $3.08 11/15/2021129,400 shares $427,020.00 +5.6%N/A2.6 $3.30 10/29/2021122,500 shares $422,625.00 +29.6%N/A2.7 $3.45 10/15/202194,500 shares $375,165.00 -13.6%N/A2.2 $3.97 9/30/2021109,400 shares $356,644.00 -17.3%N/A3 $3.26 9/15/2021132,200 shares $465,344.00 +20.8%1.4%4 $3.52 8/31/2021109,400 shares $421,190.00 -39.5%1.2%2.7 $3.85 8/13/2021180,700 shares $766,168.00 -14.0%1.9%4.3 $4.24 7/30/2021210,100 shares $895,026.00 +11.6%2.3%4.5 $4.26 7/15/2021188,200 shares $767,856.00 -13.4%2.0%3.2 $4.08 6/30/2021217,400 shares $1.01 million +13.3%2.3%3.1 $4.65 6/15/2021191,900 shares $871,226.00 -34.9%2.1%1.6 $4.54 5/28/2021294,800 shares $1.29 million +0.9%3.2%1.4 $4.38 5/14/2021292,200 shares $1.13 million -7.6%3.2%0.2 $3.86 4/30/2021316,100 shares $1.33 million +11.8%3.5%0.2 $4.22 4/15/2021282,700 shares $1.10 million +2.4%N/A0 $3.90 3/31/2021276,100 shares $1.36 million -5.9%3.1%0.1 $4.94 3/15/2021293,400 shares $1.53 million +1,646.4%3.5%0.2 $5.23 2/26/202116,800 shares $54,536.16 -15.6%0.2%0 $3.25 2/12/202119,900 shares $76,217.00 +7.6%0.2%0.3 $3.83 1/29/202118,500 shares $56,980.00 -29.7%0.2%0.3 $3.08 1/15/202126,300 shares $80,478.00 No Change0.3%0.6 $3.06 10/30/202024,000 shares $89,520.00 +220.0%N/A2.5 $3.73 10/15/20207,500 shares $31,091.25 +5.6%N/A0.6 $4.15 9/30/20207,100 shares $26,625.00 No ChangeN/A1.5 $3.75 9/15/20207,100 shares $28,684.00 -1.4%N/A1.2 $4.04 3/13/202028,900 shares $5,780.00 +381.7%N/A0.4 $0.20 2/28/20206,000 shares $1,500.00 +66.7%N/A0.1 $0.25 2/14/20203,600 shares $934.56 -71.2%N/A0 $0.26 1/31/202012,500 shares $3,093.75 -69.1%N/A0.2 $0.25 1/15/202040,400 shares $8,484.00 +4,388.9%N/A0.6 $0.21 12/31/2019900 shares $192.15 +12.5%N/A0 $0.21 INVO Short Interest - Frequently Asked Questions What is INVO Bioscience's current short interest? Short interest is the volume of INVO Bioscience shares that have been sold short but have not yet been covered or closed out. As of September 30th, traders have sold 2,000 shares of INVO short. 0.05% of INVO Bioscience's shares are currently sold short. Learn More on INVO Bioscience's current short interest. What is a good short interest percentage for INVO Bioscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.05% of INVO Bioscience's floating shares are currently sold short. Is INVO Bioscience's short interest increasing or decreasing? INVO Bioscience saw a decrease in short interest in September. As of September 30th, there was short interest totaling 2,000 shares, a decrease of 96.6% from the previous total of 58,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is INVO Bioscience's float size? INVO Bioscience currently has issued a total of 3,809,000 shares. Some of INVO Bioscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. INVO Bioscience currently has a public float of 3,880,000 shares. How does INVO Bioscience's short interest compare to its competitors? 0.05% of INVO Bioscience's shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to INVO Bioscience: STRATA Skin Sciences, Inc. (0.24%), Lyra Therapeutics, Inc. (3.36%), PolyPid Ltd. (0.45%), SeaStar Medical Holding Co. (7.88%), PAVmed Inc. (3.12%), NeuroMetrix, Inc. (2.13%), T2 Biosystems, Inc. (12.57%), Biotricity, Inc. (17.03%), Plus Therapeutics, Inc. (1.98%), Intelligent Bio Solutions Inc. (11.85%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.04 billion), AppLovin Co. ($2.69 billion), Nu Holdings Ltd. ($2.64 billion), Paychex, Inc. ($2.61 billion), Cencora, Inc. ($2.30 billion), Aptiv PLC ($2.09 billion), Moderna, Inc. ($2.09 billion), Tractor Supply ($2.04 billion), Coinbase Global, Inc. ($1.97 billion), and International Paper ($1.95 billion). View all of the most shorted stocks. What does it mean to sell short INVO Bioscience stock? Short selling INVO is an investing strategy that aims to generate trading profit from INVO Bioscience as its price is falling. INVO shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against INVO Bioscience? A short squeeze for INVO Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INVO, which in turn drives the price of the stock up even further. How often is INVO Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INVO, twice per month. The most recent reporting period available is September, 30 2024. More Short Interest Resources from MarketBeat Related Companies SSKN Short Interest LYRA Short Interest PYPD Short Interest ICU Short Interest PAVM Short Interest NURO Short Interest TTOO Short Interest BTCY Short Interest PSTV Short Interest INBS Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INVO) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
